Knappschaftsklinikum Saar GmbH — Clinical Trial Site

10 Registered trials

2 Currently recruiting

Organisation

Knappschaftsklinikum Saar GmbH

Location

Sulzbach, Germany

Identifier

ORG-100044465

Address

An Der Klinik 10, 66280, Germany

Departments

276014: Augenklinik Sulzbach
Augenklinik
Augenklinik Sulzbach
Department of Ophthalmology
Klinik für Augenheilkunde
Ophthalmology

Clinical trials at this site (10)

Search interface

A clinical trial to assess the efficacy and safety of ADX-308, a new type of treatment for Geographic Atrophy (GA), an advanced stage of eye… Pending

2025-521779-30-00 Geographic atrophy secondary to age-related macular deg 4
Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER). Recruiting

2023-504751-28-00 Exudative age-related macular degeneration 5 2024-09-24
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
A Study to Evaluate Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-Related … Ended

2023-507131-38-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2022-05-16
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System with Ranibizumab in Patients … Ended

2023-507130-24-00 Neovascular age-related macular degeneration (nAMD) 5 2021-10-22
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ended

2023-506707-25-00 Choroidal neovascularization secondary to pathologic my 5 2024-04-09
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
A STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WIT… Ended

2022-501794-39-00 Uveitic Macular Edema 5 2023-06-28
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma Ended

2024-511254-51-00 Glaucoma 1 2023-02-09
Early Reperfusion Therapy for Recovery of Vision in Acute Central Retinal Artery Occlusion Ended

2023-507388-21-00 Acute non-arteritic central retinal artery occlusion (C 5 2022-09-08